


| business World's first clinical trial of non-viral PD1 specific targeted CAR T therapy achieves great breakthroughs PR Newswire Asia |
|
SHANGHAI Sept. 28, 2020 /PRNewswire/ -- On September 25, 2020 , BIORAY LABORATORIES Inc. ("Bioraylab"), a company specialized in gene therapy and cell drug R&D, announced for the first time that clinical trials of non-viral PD1 specific targeted CAR T therapy in relapsed/refractory B-cell....
Posted: 2020-09-28 14:37:00
|
If you are a broadcaster or Christian program producer you can schedule a 15 min FREE consultation with an EGR specialist to help you evaluate all possible Int'l broadcasting options.
We will call you back at a number and time of your convenience, and will gladly answer any question that you may have on how to broadcast your Christian message worldwide.